ARMISTICE CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Rigel Pharmaceuticals, Inc. (RIGL)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Rigel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: RIGL
Shares outstanding: 17.6M shares
Disclosed Ownership: 1.15M shares
Ownership: 6.54%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 05:18 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	6.54%	1.15M	0	1.15M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	6.54%	1.15M	0	1.15M	/s/ Steven Boyd	Steven Boyd